Burning Rock Biotech (BNR) Free Cash Flow (2019 - 2026)

Burning Rock Biotech's Free Cash Flow history runs 8 years deep, the most recent figure standing at -$4.2 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 31.25% year-over-year to -$4.2 million; the TTM figure through Mar 2026 stood at -$15.4 million (up 58.93% YoY), while the FY2025 annual figure was -$4.8 million, up 64.5% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$4.2 million, down from -$4.0 million in the prior quarter.
• The five-year high for Free Cash Flow was $2.3 million in Q3 2025, with the low at -$22.8 million in Q1 2022.
• The 5-year median for Free Cash Flow is -$9.5 million (2025), against an average of -$9.5 million.
• The sharpest annual moves came in 2024 and 2025: Free Cash Flow tumbled 468.89% in 2024, then soared 114.52% in 2025.
• Burning Rock Biotech's Free Cash Flow stood at -$9.5 million in 2022, then surged by 76.3% to -$2.3 million in 2023, then sank by 468.89% to -$12.8 million in 2024, then soared by 68.81% to -$4.0 million in 2025, then fell by 6.12% to -$4.2 million in 2026.
• Business Quant data shows BNR's Free Cash Flow at -$4.2 million in Q1 2026, -$4.0 million in Q4 2025, and $2.3 million in Q3 2025.